Table 1.

Teaching points

•Patients with atopic dermatitis showed improvement of MGN following treatment with dupilumab.

•Dupilumab had few side effects compared to cytotoxic or broad immunosuppressive therapies for MGN.

•IL-4R could potentially be targeted as a therapeutic for antibody-mediated autoimmunity.

MGN, membranous glomerulonephritis.